Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Evaluation of targets for Strongyloides genus specific molecular diagnosis in experimental strongyloidiasis

Full text
Author(s):
Nascimento, Rafael C. [1, 2] ; Melo, Gessica B. [1, 2] ; Fonseca, Priscilla D. M. [1, 2] ; Gryschek, Ronaldo C. B. [1, 2] ; Paula, F. M. [1, 2]
Total Authors: 5
Affiliation:
[1] Univ Sao Paulo, Inst Med Trop, Fac Med, Sao Paulo - Brazil
[2] Univ Sao Paulo, Hosp Clin, Fac Med, Lab Invest Med LIM 06, Sao Paulo - Brazil
Total Affiliations: 2
Document type: Journal article
Source: Experimental Parasitology; v. 230, NOV 2021.
Web of Science Citations: 0
Abstract

Strongyloides venezuelensis has been used in different experimental studies, such as those aimed at the evaluation of diagnostic techniques for human strongyloidiasis, mainly the molecular diagnosis. In this study, three regions (genus, 18S and 28S targets) of Strongyloides ribosomal DNA were evaluated for the molecular diagnosis of experimental strongyloidiasis. Rats were infected subcutaneously with 400 or 4000 S. venezuelensis infective larvae (400iL3 and 4000iL3), and kept for 35 days. Fecal samples were collected daily to count eggs per gram of feces (EPG) and to perform the polymerase chain reaction (PCR). Egg count started on the 5th day post-infection (pi) and ended on days 33 and 34 pi, in 400iL3 and 4000iL3 groups, respectively. Based in EPG, fecal samples were selected from days 2, 5, 8, 11, 15, 23 and 35 pi for DNA extraction; PCR (genus, 18S and 28S); and sequencing. The PCR-28S products showed higher values of identity (95-100%) in the database with the Strongyloides sequences. Therefore, it is possible to reinforce the application of PCR-28S in the diagnosis of experimental and human strongyloidiasis. (AU)

FAPESP's process: 16/06185-0 - Proteomic analysis of evolutionary stages from Strongyloides venezuelensis
Grantee:Fabiana Martins de Paula
Support Opportunities: Regular Research Grants